Covered recipient · General Payments record
ABHIJEET KASHYAP
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,308.31
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $740.26 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $293.24 | 15 |
| BOSTON SCIENTIFIC CORPORATION | $147.58 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.02 | 2 |
| Celgene Corporation | $61.15 | 3 |
| PFIZER INC. | $45.63 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.89 | 1 |
| GENZYME CORPORATION | $30.16 | 1 |
| Regeneron Healthcare Solutions, Inc. | $29.79 | 1 |
| Fresenius Kabi USA, LLC | $17.72 | 1 |
| Organon LLC | $15.08 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.71 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036191 | CMS |
| ABBVIE INC. | $22.76 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036193 | CMS |
| ABBVIE INC. | $17.71 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036195 | CMS |
| ABBVIE INC. | $22.84 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036197 | CMS |
| ABBVIE INC. | $18.27 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036199 | CMS |
| ABBVIE INC. | $20.81 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036201 | CMS |
| ABBVIE INC. | $16.93 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036203 | CMS |
| ABBVIE INC. | $16.73 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036205 | CMS |
| ABBVIE INC. | $19.94 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036207 | CMS |
| ABBVIE INC. | $19.78 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036209 | CMS |
| ABBVIE INC. | $24.16 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036211 | CMS |
| ABBVIE INC. | $17.21 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036213 | CMS |
| ABBVIE INC. | $18.89 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036215 | CMS |
| ABBVIE INC. | $18.14 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036217 | CMS |
| ABBVIE INC. | $17.36 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104036219 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.89 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118122867 | CMS |
| Boston Scientific Corporation | $147.58 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092238560 | CMS |
| Celgene Corporation | $22.19 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101140592 | CMS |
| Celgene Corporation | $16.70 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101140590 | CMS |
| Celgene Corporation | $22.26 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101140600 | CMS |
| Fresenius Kabi USA, LLC | $17.72 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146947583 | CMS |
| GENZYME CORPORATION | $30.16 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139737238 | CMS |
| Organon Llc | $0.93 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136283147 | CMS |
| Organon Llc | $14.15 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136283152 | CMS |
| PFIZER INC. | $18.69 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132060730 | CMS |
| PFIZER INC. | $13.37 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132059698 | CMS |
| PFIZER INC. | $13.57 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132058806 | CMS |
| Regeneron Healthcare Solutions, Inc. | $29.79 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114082687 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.92 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137596194 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.10 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137596197 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.